Dr. Ontiveros is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
210 W McKinley Ave
Ste 1
Decatur, IL 62526Phone+1 217-879-6600Fax+1 217-876-6606
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Hematology and Medical Oncology, 2007 - 2010
University of Alabama Medical CenterResidency, Internal Medicine, 2004 - 2007
University of Iowa Roy J. and Lucille A. Carver College of MedicineClass of 2004
Certifications & Licensure
CA State Medical License 2007 - Present
IL State Medical License 2017 - 2026
NY State Medical License 2013 - 2017
IA State Medical License 2012 - 2014
AL State Medical License 2005 - 2007- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 39 citationsPharmacogenetics predictive of response and toxicity in acute lymphoblastic leukemia therapy.Lin Mei, Evelena P. Ontiveros, Elizabeth A. Griffiths, James E. Thompson, Eunice S. Wang
Blood Reviews. 2015-07-01 - 69 citationsNCCN guidelines® insights: Chronic myeloid leukemia, version 1.2017: Featured updates to the NCCN guidelinesArnel Pallera, Jessica K. Altman, Ellin Berman, Camille N. Abboud, Bhavana Bhatnagar
Journal of the National Comprehensive Cancer Network. 2016-12-01 - 15 citationsDexrazoxane for cardioprotection in older adults with acute myeloid leukemiaPankit Vachhani, Sarah Shin, Jeffrey Baron, James E. Thompson, Meir Wetzler
Leukemia Research Reports. 2017-01-01
Journal Articles
- Intensive Chemotherapy vs. Hypomethylating Agents in Older Adults with Newly Diagnosed High-Risk Acute Myeloid Leukemia: A Single Center ExperiencePankit Vachhani, Evelena P Ontiveros, Leukemia Research
- Intensive Chemotherapy vs. Hypomethylating Agents in Older Adults with Newly Diagnosed High-Risk Acute Myeloid Leukemia: A Single Center ExperiencePankit Vachhani, Evelena P Ontiveros, Leukemia Research
Authored Content
- Intensive Chemotherapy vs. Hypomethylating Agents in Older Adults with Newly Diagnosed High-Risk Acute Myeloid Leukemia: A Single Center ExperienceOctober 2018
Professional Memberships
- Member
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
